The Pathophysiology and Treatment of Sepsis
Richard S. Hotchkiss, Irene E. Karl
New England Journal of Medicine · 2003 · 4,134 citations
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Hotchkiss, R. S., & Karl, I. E. (2003). The pathophysiology and treatment of sepsis. New England Journal of Medicine, 348(2), 138–150. https://doi.org/10.1056/nejmra021333
In text: (Hotchkiss & Karl, 2003)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Sepsis is the leading cause of death in critically ill patients in the United States. Yet the individual host response to septicemia is variable, depending on the patient's immune response, age, nutritional status, and coexisting conditions, as well as on the virulence of the organism and the size of the inoculum. This review examines evolving concepts of sepsis and discusses new and potential therapies. Recent clinical advances include therapy with activated protein C, stringent control of blood glucose, and early goal-directed therapy to treat cellular oxygen deficit. Future therapies may be focused on modulating the immune response in the light of the characteristics of the specific pathogen, the genetic profile of the patient, and the duration of the disease.
Related papers
- APACHE II1985
- Intensive Insulin Therapy in Critically Ill Patients2001
- Intensive versus Conventional Glucose Control in Critically Ill Patients2009
- Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient2016
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes2017
Metadata from OpenAlex (CC0). Citations are generated from the published record.